Contributions to the Study of Psychosocial Aspects in Hematologic Malignancies

Similar documents
Explainer: what are personality disorders and how are they treated?

Teenagers Who Have Been Diagnosed With Cancer Are Fighting for a Better Future

UNC CFAR Social and Behavioral Science Research Core SABI Database

SECTION 1. Children and Adolescents with Depressive Disorder: Summary of Findings. from the Literature and Clinical Consultation in Ontario

Primary Care: Referring to Psychiatry

Can my personality be a disorder?!

Chapter 2 Lecture. Health: The Basics Tenth Edition. Promoting and Preserving Your Psychological Health

INTERCONTINENTAL JOURNAL OF HUMAN RESOURCE RESEARCH REVIEW A STUDY ON PSYCHOSOMATIC DISORDER AND WORKING WOMEN

GENERAL CRISIS SITUATIONS. Acknowledgements: Most of the information included in this chapter was obtained from the Handbook of

WHAT ARE PAEDIATRIC CANCERS

Depression. Content. Depression is common. Depression Facts. Depression kills. Depression attacks young people

Live patient discussion Sandra Ros (MA), Dr Lluís Puig

Pain-related Distress: Recognition and Appropriate Interventions. Tamar Pincus Professor in psychology Royal Holloway University of London

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE. Personality Disorder: the clinical management of borderline personality disorder

Copyright 2014 McGraw-Hill Education. All rights reserved. No reproduction or distribution without the prior written consent of McGraw-Hill

Palliative Care in Adolescents and Young Adults Needs, Obstacles and Opportunities

VI.2 Elements for a Public Summary DULOXETINE Pharmalex 30 mg hard gastro-resistant capsules DULOXETINE Pharmalex 60 mg hard gastro-resistant capsules

INDIVIDUALS ARE COPING ALL THE TIME.

Chapter 3 Self-Esteem and Mental Health

ENGAGING AND SUPPORTING FAMILIES IN SUICIDE PREVENTION

Slide 1. Slide 2. Slide 3 Similar observations in all subsets of the disorder. Personality Disorders. General Symptoms. Chapter 9

Trauma and Children s Ability to Learn and Develop. Dr. Katrina A. Korb. Department of Educational Foundations, University of Jos

ACGME Program Requirements for Graduate Medical Education in Pediatric Hematology-Oncology

Useful Self Assessment tools to help identify your needs and how you are feeling for patients and their family/caregivers

Depression: what you should know

Suicide Prevention in the Older Adult

Dynamics of Disease. Elizabeth Archer-Nanda, PMHCNS-C. Collaborators: Mary Helen Davis, MD Sarah Parsons, DO Rose Vick, PMHNP-C

Can my personality be a disorder?!

These conditions can be short or long term, they can come and go, and there is no way of knowing who will be affected by them.

Mental Health Awareness

Mood, Emotions and MS

LYMPHOMA Joginder Singh, MD Medical Oncologist, Mercy Cancer Center

The Psychology of Chronic Illness

Condensed Clinical Practice Guideline Treatment Of Patients With Schizophrenia

Dr. Catherine Mancini and Laura Mishko

Dr Rikaz Sheriff. Senior Medical Officer, Western Hospital

Typical or Troubled? Teen Mental Health

Child/ Adolescent Questionnaire

Understanding Psychiatry & Mental Illness

Psych Grand Rounds. Disclosure. My books

Obsessive-Compulsive Disorder Clinical Practice Guideline Summary for Primary Care

The Suffering in patients with Metastatic Breast Cancer

ASWB LMSW Exam. Volume: 261 Questions

Understanding MCL and finding the right treatment for you

Winter Night Shelters and Mental Healh Barney Wells, Enabling Assessment Service London.

HERTFORDSHIRE PARTNERSHIP UNIVERSITY NHS FOUNDATION TRUST. Referral Criteria for Specialist Tier 3 CAMHS

Awareness of Borderline Personality Disorder

Coming off Medication By Guy Holmes and Marese Hudson

New Research in Depression and Anxiety

Personality Disorders

5/6/2008. Psy 427 Cal State Northridge Andrew Ainsworth PhD

Depression in the Eldery Handout Package

Pediatric Oncology. Vlad Radulescu, MD

Typical or Troubled? By Cindy Ruich, Ed.D. Director of Student Services Marana Unified School District Office:(520)

Hilary Planden October 27, 2011

SEPARATION ANXIETY. Ana Figueroa, Cesar Soutullo, Yoshiro Ono & Kazuhiko Saito. ANXIETY DISORDERS Chapter F.2. Adapted by Julie Chilton

UW MEDICINE PATIENT EDUCATION. Baby Blues and More DRAFT. Knowing About This in Advance Can Help

Client Intake Form. First Name: M.I.: Last Name: Birthdate: Gender: Age: Address: City: State: Zip:

Wellness along the Cancer Journey: Palliative Care Revised October 2015

AN OVERVIEW OF ANXIETY

Symptoms and features, two explanations and two treatments of unipolar depression Symptoms and features of unipolar depression

Dr Carmelo Aquilina Senior Staff Specialist & Service Director Sydney West Area Health Service Clinical Senior Lecturer, University of Sydney

4. General overview Definition

Single Technology Appraisal (STA) Midostaurin for untreated acute myeloid leukaemia

WHAT ARE PERSONALITY DISORDERS?

Feeling depressed? Feeling anxious? What may help. What may help

Depressive, Bipolar and Related Disorders

St George Hospital Renal Supportive Care Psychosocial Day, 10 th August Michael Noel, Supportive and Palliative Care Physician, Nepean Hospital

PANDAS/PANS DIAGNOSIS AND TREATMENT. Sophie Fowler FNP-BC

CHAPTER 7 SUICIDAL BEHAVIOUR. Highlights

Intro to Concurrent Disorders

Mental Health 101. Workshop Agreement

Prescribing for people with a personality disorder. POMH-UK QIP 12b

1/3/2008. Karen Burke Priscilla LeMone Elaine Mohn-Brown. Medical-Surgical Nursing Care, 2e Karen Burke, Priscilla LeMone, and Elaine Mohn-Brown

Cluster 1 Common Mental Health Problems (mild)

LIMPSFIELD GRANGE SCHOOL. Self-Harming Policy

Patient Experience Research in Malignant Hematology: describing the lived experience of illness with acute myeloid leukemia

Neurotic and Personality Disorders

Eating Disorders. Eating Disorders. Anorexia Nervosa. Chapter 11. The main symptoms of anorexia nervosa are:

Depression And The Body

Intake Questionnaire For New Adult Patients

Psychosis, Mood, and Personality: A Clinical Perspective

Journey to Truth Counseling

Patient Questionnaire. Name: Date: A. What are the main concerns or problems that brought you here today?

Other significant mental health complaints

Approach to the Patient with Borderline Personality Disorder in Primary Care

10/8/2014. Quality of Life: On score of 0 (poor) 10 (excellent): MDS average = 5.1. Normal average = 7.7

How to Manage Anxiety

Borderline Personality Disorder and Addiction. What s in a name? DSM-IV TR Diagnostic Criteria. Erica Hoff, PhD Licensed Clinical Psychologist

Overview. Classification, Assessment, and Treatment of Childhood Disorders. Criteria for a Good Classification System

Personality Disorders Explained

Appendix F- Edmonton Symptom Assessment System (ESAS), Canadian Problem Checklist, and Distress Thermometer for Cancer Patients

Charles Schroeder EMS Program Manager NM EMS Bureau

Emotions After Giving Birth

ANXIETY AND DEPRESSIVE NEUROSIS - THEIR RESPONSE TO ANXIOLYTIC AND ANTIDEPRESSANT TREATMENT GURMEET SINGH 1 R. K. SHARMA 2 SUMMARY

UW MEDICINE PATIENT EDUCATION. Baby Blues and More. Postpartum mood disorders DRAFT. Emotional Changes After Giving Birth

END OF LIFE CONVERSATIONS The Social Worker Modeling Patient and Family Communication within the Interdisciplinary Team

New Client Information. address: Date of Birth:

Screening for Depression and Suicide

The Science and Psychology of Infertility

Transcription:

: 25-29 Copyright Celsius Original Paper Contributions to the Study of Psychosocial Aspects in Hematologic Malignancies Amelia Maria Gãman 1,2, M. A. Gãman 3 1 University of Medicine and Pharmacy of Craiova, Romania 2 Clinic of Hematology, Filantropia Hospital of Craiova, Romania 3 Carol Davila University of Medicine and Pharmacy of Bucharest, Romania REZUMAT Contribuåii la studiul unor aspecte psihosociale în hemopatiile maligne Hemopatiile maligne sunt afecåiuni severe, cu sfâræit letal dacã nu sunt tratate, care se însoåesc de un rãspuns emoåional la stresul acut determinat de aflarea diagnosticului de hemopatie malignã æi tratamentul acesteia, ce poate apãrea în orice moment al bolii: comunicarea diagnosticului, începerea tratamentului, recãderea, ineficienåa tratamentului, progresia bolii. Rãspunsul emoåional poate îmbrãca mai multe aspecte: stare de æoc, negare, fricã, pierderea speranåei, anxietate, depresie, perturbarea dezvoltãrii personalitãåii, alterãri ale somnului æi apetitului. Factorii care influenåeazã rãspunsul psihosocial sunt stabilitatea emoåionalã a persoanei anterior aflãrii diagnosticului æi existenåa suportului social. Hemopatiile maligne asociazã multe aspecte emoåionale æi sociale care necesitã, pe lângã tratamentul specific al bolii (chimioterapie, radioterapie, transplant medular) æi un tratament psihologic (agenåi psihofarmacologici, psihoterapie individualã sau de grup) pentru adaptarea psihosocialã æi îmbunãtaåirea calitãåii vieåii acestor pacienåi. Cuvinte cheie: hemopatii maligne, distres emoåional, aspecte psihosociale ABSTRACT Hematological malignancies are severe diseases, fatal when untreated, which associate an acute stress response described as an usual response to diagnosis and treatment of the hematologic malignancy, occuring at each transitional point of illness : communication of diagnosis, beginning of treatment, relapse, treatment failure, disease progression. The emotional response is characterized by shock, denial, fear, hopelessness, anxiety, depression, disturbance in the development of personality, sleep and apetite disturbances. The factors Corresponding author: Amelia Maria Gaman Assoc Professor of Pathophysiology University of Medicine and Pharmacy of Craiova, Romania senior specialist in hematology and internal medicine Clinic of Hematology, Filantropia Hospital of Craiova Calea Bucuresti Street, bl. 27B, ap. 18, Craiova, Romania e-mail: gamanamelia@yahoo.com

26 Amelia Maria Gãman et al which influence the psychosocial response are the emotional stability of the person before diagnosis and the existence of a social support. Hematological malignancies associate many social and emotional aspects which impose, beside specific treatment (chemotherapy, radiotherapy, bone marrow transplantation), a psychological treatment (psychopharmacological agents, individual or group psychotherapy) for psychosocial adaptation and a good quality of life for these patients. Key words: hematological malignancies, emotional distress, psychosocial aspects INTRODUCTION Hematological malignancies are severe diseases, fatal when untreated, with a profound psychosocial impact on the patient, family members, friends and society. Scientific discoveries from the last years about the understanding of the pathophysiological mechanisms of hematological malignancies and the innovative modern treatment options (including bone marrow transplantation) have changed in a favourable way the evolution and the prognosis of patients with these diseases, but brought along other consequences on the quality of life, psychoemotional aspects and social insertion. The psychological manifestations are variable, occuring at each transitional point of illness: establishment and communication of diagnosis of the hematological malignancy, beginning of treatment, evolution and disease progression. The factors which influence the psychosocial response are the emotional stability of the person before diagnosis and the existence of a social support (family members, friends, colleagues). The communication of diagnosis determined an acute emotional stress of the patient, family members and friends, because they associated the hematological malignancy with a severe disease, a specific aggressive long-term treatment, frequent and unpleasant side effects (nausea, vomiting, hair loss, sexual dysfunction, neurological complications, neutropenia etc), lenghty hospitalisation, family separation, temporary or definitive loss of social insertion, financial burden. The emotional response of the patient and family to the diagnosis of the hematological malignancy is characterised by shock, disbelief, denial, anxiety, depression, sleep and appetite disturbances, difficulty in performing everyday activities (1, 2, 3). The decision to begin and the communication of the steps of a specific treatment and side effects of chemotherapy, radiotherapy, bone marrow transplantation, surgical procedures or interventions, determined fear and hopelessness of the patient. The disclosure of medical information and the active involvement of the patient in decisions that affect him, communication between the doctor and the patient and the trust of the patient in the medical team have a major role in the success of treatment. The posibility of bone marrow transplantation, communicating the procedure and stages, presenting the risks and the benefits of this treatment determined several consequences, in the patient with a hematological malignancy treated with intensive chemotherapy with all side effects, from social isolation with a major body image disturbance and a sense of loss of control, a major life crisis with variable emotional responses, including fear for the procedure and the unknown, family isolation, anxiety or depression, to joy and hope for life (3, 4). The evolution and prognosis of the patient with hematological malignancy varies from long-term complete remission or cure to the development of a relapse after the disease free interval, progressive disease and death. Hope, faith, trust, joy for life, the discovery a new system of values from remission are rapidly interchanged with anger, hopelessness, despair during relapse or evolution followed by complications (neutropenia, sepsis, neurological complications etc) (1, 5). The factors that may have an impact on the psychosocial response are represented by the psychosocial insertion and the emotional stability of the patient before the diagnosis of a hematological malignancy, patients with a good social insertion and emotional stability being the real fighters with disease; in contrast, patients with a poor insertion, emotional instability, with communication problems are bedraggled by the disease and its consequences (3). The family and the social support are very important, with those who are able to maintain close connections with family and friends during the course of illness being more likely to cope effectively with the disease than those who are unable to maintain such relationships (6, 7).

Psychosocial Aspects in Hematologic Malignancies 27 Aim The aim of the research was to study the psychoemotional aspects in the patients with hematological malignancies, on groups of age and evolution of disease, observing anxiety and depression emergence, the evolution of personality based on some psychological manifestations and the professional integration. MATERIALS AND METHODS We studied 64 patients with hematological malignancies hospitalized in the Clinic of Hematology from Craiova, Romania (written informed consent obtained) on a period of two years, devided by groups of age, sex, area of origin, type of hematological malignancy, presence of psychoemotional aspects. We used three groups of study based on age: group A age between 16-25 years; group B age between 25-60 years; group C - age bigger than 60 years. The sex and the area of origin repartition were relatively equal in the three groups. The study was made on patients with hematological malignancies, including acute and chronic leukemias and malignant lymphomas. The diagnosis of leukemia was established by morphology, cytochemistry and in some cases by immunophenotyping and cytogenetic exam. The diagnosis of malignant lymphomas was established by lymphonode biopsies, histopatological exam, immunohistochemistry and staging on pulmonary radiography, abdominal echography, computer tomography exam, bone marrow aspiration and biopsy. We determined the haemoglobin value, white blood count and leukocyte formula, platelet counts, peripheral blood smear, bone marrow smear, usual hemostasis tests, hepatic and renal tests, glycemia, serum proteins, seric LDH. For the psychoemotional aspects and personality evolution, Hamilton's and Woodworth- Mathews's scales and a questionary for professional integration were used. The Hamilton scale calculates a global index of depression, giving useful quantitative and qualitative information about depression. For depression, Hamilton's scale has 21 questions with answers worth of 0 4 points, following depressive disposition, feeling of guilt, suicidal ideas or attempts, insomnia types, somatic equivalences of anxiety, gastrointestinal symptoms, genital symptoms, hypocondriac ideas, weight loss, adaptation. For anxiety, Hamilton`s scale has 12 questions with answers worth of 0 4 points points, following anxiety, psychic tension, cognition, sleep, somatic and vegetative symptoms, behaviour at interview (8, 9). The Woodworth Mathews questionary has 82 questions, at which the person must answer with yes or no; the questions are specially made that they may seem positive when the answer is no and negative when the answer is positive. The questions referred to excessive fatigue, environment adaptation, abnormal fears, emotional disposition, impulses, aggression etc. The questionary shows nine types of personality: 1 - emotivity (coefficient 28), 2 - obsessional and psychasthenic (coefficient 24), 3 - schizoid (coefficient 30), 4 - paranoid (coefficient 20), 5 depressive and hypochondriacal (coefficient 26), 6 impulsive and epileptic (coefficient 36), 7 insecure psychobehaviour (coefficient 52), 8 antisocial (coefficient 52), 9 tendency for hiding the truth (coefficient 26). The result is calculated by adding the drafts multiplied by the adequate coefficients. Values below 120 are normal, values between 120-240 show visible tendency, values over 240 indicate disease. The questionary about school or professional integration evaluated the integration in the professional activity, school or professional performances, loss of interest for the professional activities, decreased attention, presence of memory disturbances, relationship with colleagues. RESULTS AND DISCUSSIONS The three study groups had the following components: group A (age between 16-25 years) = 8 patients (5 cases with acute leukemia, one case of chronic myeloid leukemia, 2 cases of Hodgkin`s disease); group B (age between 25-60 years) = 26 patients (6 cases of acute leukemia, 7 cases of chronic myeloid leukemia, 3 cases of chronic lymphocytic leukemia, 3 cases of Hodgkin`s disease, 7 cases of non-hodgkin`s lymphomas); group C (age over 60 years) = 30 patients (2 cases of acute leukemia, 8 cases of chronic myeloid leukemia, 14 cases of chronic lymphocytic leukemia, one case of Hodgkin`s disease, 5 cases of non Hodgkin`s lymphomas). The scores for depression were bigger in the groups B and C; the stress of diagnosis communication and the changes in couple relationship were the bottom causes of depression. At six persons from group B and three persons from group C symptoms of masked depression were present. The distribution of scores for anxiety was heterogenous in the three groups. Three patients from group A presented emotional instability and two from group

28 Amelia Maria Gãman et al Table 1. The distribution of relevant psychological manifestations based on age groups No. crt. Symptoms Group A (no. cases) Group B (no. cases) Group C (no. cases) 1. Culpability 2 14 21 2. Fear of being deserted 6 8 8 3. Other phobias 1 10 2 4. Depression 1 20 2 5. Paranoid 0 2 1 6. Obsessive, impulsive 2 3 0 7. Cognitive deficiency 0 2 16 8. Sleep disturbances 1 12 26 9. Suicidal attempt 1 1 0 B developed simple emotivity. The distribution of relevant psychological manifestations, based on age groups (Table 1), showed an increased emotional response related to the fear of being deserted, isolated from family and friends, impulsive and suicidal tendencies in group A, in the younger patients with emerging personality, emotionally more unstable, in the recently formed couples. In the patients with active age (group B) with family and family responsabilities, with a high socio-professional insertion, the feelings of culpability, depression and failure, sleep disturbances, fear of losing their job, decreased income and of family isolation were predominant. The patients from group C (mostly pensioners) showed predominant feelings of culpability, sleep disturbances, cognitive deficiencies, the fear of being deserted. In almost half of the cases from group C, capitulation in front of disease and evolution appeared; at three patients, obsessive religious concerns appeared. The evaluation of integration in school or in the socio-professional activity showed that three of five patients from group A with school with acute leukemias interrupted school temporarily due to long-term hospitalization, complications induced by chemotherapy, fatigue, body image disturbance. Two patients continued studies in complete remission with a decreased interest of study, shallowness, listlessness or aggresion in the relationships with colleagues. In all cases, the attitude of colleagues was positive. Patients aged 18 to 26 interrupted temporarily or definitively their activity (four of them presented problems related to adaptation and social insertion, which imposed giving up the professional activity); eight patients in complete remission continued their activity, three of them with changes in work site. The attitude of colleagues was positive, sometimes even protective. A real problem was differentiating psychoemotional responses from psychiatric disorders. In one case, acute leukemia appeared in a patient with schizophrenia and major problems of communication emerged, especially as the patient's mother was schizophrenic too and the father decided to abandon the family. Four patients with hematological malignancies developed severe depression and needed psychiatric treatment. The management of psychosocial problems of the patients with hematological malignancies included anxiety, depression, body image disturbances, pain, disease or specific treatment complications (nausea, vomiting, hair loss, sexual dysfunctions) that required anxiolytics, antidepressive, pain relievers, antinauseants, psychotherapy, family involvement for improving the quality of life of these patients and insertion in family and society. CONCLUSIONS 1. The acute emotional stress is present in all patients with hematological malignancies, with variable manifestations from anxiety, depression, personality disturbances to suicidal tendencies and the development of real psychiatric disorders. 2. The factors which influence the psychosocial responses of the patients with hematological malignancies are the emotional stability of the person before diagnosis, the sociocultural level and the existence of family and friend support. 3. The creation of a psychological personal record and of a different approach of the patients based on the types of personality in the communication of diagnosis, treatment stages and evolution of

Psychosocial Aspects in Hematologic Malignancies 29 disease is necessary. 4. The inclusion in the medical team from hemato-oncology clinics of a medical psychologist is essential for assuring the psychoemotional support of the patients and members of the family on the full evolution of disease. 5. The individual approach of the patient must be based on the specific particularities of the age group. 6. The association of an anxiolytic or antidepressive treatment, individual and group psychotherapy to the patients with hematological malignancies are necessary for overcoming the moment of diagnosis, beginning of treatment and assuring the psychological support in the relapse or progression of disease or in socio-professional insertion in the case of a complete remission. REFERENCES 1. Bauld C, Anderson V, Arnold J. Psychosocial aspects of adolescent cancer survival. J Paediatr Child Health. 1998;34(2):120-6. 2. Gaman AM Emotional stress on patients with acute leukemias, Abstract book of 39th Annual ISPNE Conference, Dresda, 2008. 3. Pasacreta JV, McCorkle R. Psyhosocial Aspects of Hematologic Disorders. In Hematology:Basic Principles and Practice, R Hoffman, EJ Benz Jr, S J Shattil, B Furie, HJ Cohen, LE Silberstein, P McGlave eds, 3rd edition. New York: Churchill Livingstone; 2000. p. 1514-1521. 4. Holder D, Inkster S. Psychosocial effects of bone marrow transplantation. Nurs Times. 1994;90(39):44-5. 5. Noll RB, MacLeon WE Jr, Whitt JK, et al. Behavioral adjustment and social functioning of long-term survivors of childhood leukemia: parent and teacher reports. J Pediatr Psychol. 1997; 22(6):827-41. 6. Charles K, Sellick S, Montesanto B, et al. Priorities of cancer survivors regarding psychosocial needs. J. of Psychosocial Oncology. 1996;14:57. 7. Fawzy F, Fawzy NW, Arndt LA, et al. Critical review of psyhosocial interventions in cancer care. Arch Gen Psychiatry. 1995;52(2):100-13. 8. Bech P, Doppen A. The Hamilton scales. Berlin: Springer Verlag; 1990. 9. Hamilton RJ, Akjter S. Psychometric properties of the multidimensional multiattributional causality scale. Educational and Psychological measurement. 2002;62(5):802-17. 10. Gorgos C. Vademecum în psihiatrie, Ed. Medicalã Bucureæti, 1985.